Technological Advancements Drive Middle East & Africa Automated External Defibrillators Market
There is a rise in technological advancements and increased investments in defibrillators by private players. In August 2022, Asahi Kasei (ZOLL) Medical Corporation introduced the Asahi Kasei (ZOLL) AED 4 defibrillator with integrated Wi-Fi connectivity for remote monitoring and data management, enhancing ease of use and maintenance. Similarly, in May 2023, Boston Scientific launched the EMPOWER External Defibrillator with smart features, including mobile app connectivity, patient education resources, and remote monitoring capabilities. In September 2019, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. launched the BeneHeart C Series of AEDs with intelligent operations and faster shock delivery to achieve better recovery outcomes for sudden cardiac arrest (SCA). The product range is available in fully automatic and semi-automatic versions that offer up to 360 Joules and are integrated with unique ResQNavi technology. Thus, the launch of new products due to the rise in technological advancements is leading to significant future trends in the automated external defibrillator market.Middle East & Africa Automated External Defibrillators Market Overview
The Middle East & Africa automated external defibrillators market is segmented into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Government initiatives to strengthen pharmaceutical development and rising cases of cardiac diseases is propelling the market in this region. Saudi Arabia is among the fastest-developing regions in the Middle East & Africa, with a large population base and rising chronic disease prevalence. Saudi Arabia's healthcare system is a national healthcare system; with this system, the government offers free medical services through a variety of government entities.As per the Ministry of Health in Saudi Arabia, approximately 23 million people will suffer from CVDs by 2030. This is mainly due to rapid socio-economic growth such as a paradigm shift in lifestyle and a rise in the intake of low-quality cholesterol-laden meals and a sedentary lifestyle. Additionally, the World Economic Forum (WEF) reports that the Middle East recorded a rising incidence of noncommunicable diseases (NCDs), among which CVDs are the leading disease across the region, accounting for the highest mortality rates. According to records, one in four adults suffer from CVDs in Saudi Arabia, increasing the risk of getting heart attacks within the next ten years.
Middle East & Africa Automated External Defibrillators Market Segmentation
The Middle East & Africa automated external defibrillators market is segmented into type, end user, and country.Based on type, the Middle East & Africa automated external defibrillators market is bifurcated into fully-automated external defibrillators and semi- automated external defibrillators. The fully-automated external defibrillators segment held a larger share of the Middle East & Africa automated external defibrillators market in 2022.
Based on end user, the Middle East & Africa automated external defibrillators market is segmented into hospitals & clinics, homecare, and others. The hospitals & clinics segment held the largest share of the Middle East & Africa automated external defibrillators market in 2022.
Based on country, the Middle East & Africa automated external defibrillators market is segmented into the UAE, South Africa, Saudi Arabia, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa automated external defibrillators market in 2022.
Asahi Kasei Corp, Koninklijke Philips NV, Nihon Kohden Corp, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co Ltd, and Stryker Corp are some of the leading companies operating in the Middle East & Africa automated external defibrillators market.
Table of Contents
Companies Mentioned
- Asahi Kasei Corp
- Koninklijke Philips NV
- Nihon Kohden Corp
- Schiller AG
- Shenzhen Mindray Bio-Medical Electronics Co Ltd
- Stryker Corp